On Wednesday, July 9, 2014, executives and guests of TransEnterix will visit the NYSE.
The common shares of TransEnterix began trading on NYSE MKT under the ticker symbol "TRXC" in April, 2014.
To mark the occasion, TransEnterix Chief Executive Officer Todd M. Pope will ring The Opening Bell®.
About TransEnterix (NYSE MKT: TRXC)
TransEnterix is a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery. The company is focused on the development and commercialization of the SurgiBot™ system, a minimally invasive surgical robotic system that allows the surgeon to be patient-side within the sterile field.
